Clinical Trial Update: Capecitabine in the Perioperative Treatment of Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating capecitabine in perioperative treatment for rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Rectal Cancer | Phase 3 | Status: COMPLETED